Ledger.Open graph →
SEC Form D · filed December 28, 2017

Millendo Therapeutics, Inc

Offering
$59.1M
Sold
$50.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
ANN ARBOR, MI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Carole Neuchterlein · Ann Arbor, MIDirectorJeffery Brinza · Ann Arbor, MIExecMary Lynne Hedley · Ann Arbor, MIDirectorPharis Mohideen · Ann Arbor, MIExecJames Hindman · Ann Arbor, MIDirectorChristopher Seiter · Ann Arbor, MIExecThierry Abribat · Ann Arbor, MIDirectorJames Topper · Seattle, WADirectorRandall Whitcomb · Richmond, VADirectorJulia Owens · Ann Arbor, MIExec · DirectorCarol Gallagher · San Diego, CADirectorThierry Abribat · Ann Arbor, MIDirectorPharis Mohideen · Ann Arbor, MIExecJames Hindman · Ann Arbor, MIDirectorChristopher Seiter · Ann Arbor, MIExecJames Topper · Newton, MADirectorRandall Whitcomb · Ann Arbor, MIDirectorJulia Owens · Ann Arbor, MIExec · DirectorCarol Gallagher · San Diego, CADirectorCarole Neuchterlein · Ann Arbor, MIDirectorJeffery Brinza · Ann Arbor, MIExecMary Lynne Hedley · Waltham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗